Archives
-
Rotavirus NSP4 Rewires the Necroptosis Machinery
2026-09-18
A 2024 study identifies rotavirus NSP4 as the viral trigger that links endoplasmic-reticulum calcium release to RIPK1-RIPK3-MLKL necroptosis. Its central advance is showing that NSP4 recruits RIPK1 without requiring RIPK1 kinase activity, while calcium-dependent RIPK3 engagement and MLKL phosphorylation complete the death pathway.
-
Heart–Brain Axis Dysregulation in PTSD Mice
2026-09-17
A 2026 European Journal of Pharmacology study identifies a vagal cardiac-to-insular pathway that links sympathetic cardiac overactivation with PTSD-like behavior in mice. By combining stress modeling, chronic isoproterenol exposure, vagotomy, electrophysiology, and propranolol treatment, the work moves beyond correlation toward a testable heart–brain mechanism with implications for neurocardiac research.
-
HLY78 and the Logic of Ligand-Dependent Wnt Control
2026-09-17
HLY78 offers translational researchers a mechanistically defined way to potentiate ligand-dependent Wnt/β-catenin signaling through Axin and LRP6. This article connects its zebrafish developmental evidence with the SFRP1–Wnt findings in oral submucous fibrosis while defining the controls needed to move from pathway activation to credible disease-model interpretation.
-
Topotecan Pharmacology and Clinical Evidence
2026-09-16
The 1999 review by Kollmannsberger and colleagues established topotecan as a water-soluble camptothecin derivative whose topoisomerase I inhibition produces replication-associated DNA damage and apoptosis. Its synthesis of pharmacokinetic, toxicity, and early clinical data remains useful for designing comparative cancer research workflows, while also highlighting renal dosing constraints and unresolved questions about schedule and combination therapy.
-
KIR2.1 Inhibition in Pulmonary Vascular Remodeling
2026-09-16
This study links KIR2.1 activity with pulmonary artery smooth muscle cell proliferation, migration, and vascular remodeling through the TGF-β1/SMAD2/3 pathway. Its combined rat model, human-cell experiments, pharmacological inhibition, and pathway blockade provide a mechanistic framework for cardiovascular ion channel research, while also highlighting limits in causal interpretation and model transferability.
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-09-15
The reference study shows that Wnt3a promotes osteogenesis by increasing O-GlcNAcylation and redirecting glucose metabolism toward aerobic glycolysis. Its mechanistic advance is the identification of PDK1 Ser174 O-GlcNAcylation as a link between Wnt signaling, PDK1 stability, glycolytic activity, and bone formation.
-
Sex-Differentiated Cannabinoid Withdrawal in Rats
2026-09-15
Brewer and colleagues show that withdrawal from the synthetic cannabinoid agonist WIN 55,212-2 differs between male and female rats in both severity-related measures and the specific behaviors that form the withdrawal phenotype. By combining rimonabant-precipitated withdrawal, spontaneous abstinence, locomotor monitoring, and delayed anxiety-like testing, the study provides a useful framework for treating sex as a biological variable in cannabinoid dependence research.
-
AZD1390: ATM Kinase Inhibitor Workflows
2026-09-14
Build mechanism-led radiation, checkpoint, and replication-stress assays with AZD1390, an ATM kinase inhibitor suited to glioma and lung cancer models. The workflow connects validated ATM biology with emerging REV1–DHX36 findings while clearly separating established evidence from testable hypotheses.
-
Amorolfine Hydrochloride: Assay Design for Fungal Stress
2026-09-14
Explore how Amorolfine Hydrochloride can support fungal infection research through ploidy-aware membrane-stress assays, mechanistic readouts, and better interpretation of antifungal susceptibility data.
-
Toremifene Citrate: From ER Mechanism to Translation
2026-09-13
A translational framework for using Toremifene Citrate to connect ERα/ERβ pharmacology with breast cancer models, exposure-aware study design, and clinically grounded interpretation.
-
WNT-Switch Cardiomyocyte Differentiation in mESCs
2026-09-12
The 2024 Cells study introduces a temporal WNT-switch protocol that uses CHIR99021 followed by XAV939 to guide mouse embryonic stem cells toward cardiomyocytes. By coordinating early WNT activation with subsequent pathway inhibition, the method improves beating-cell yield while reducing treatment complexity and providing a practical model for cardiac development research.
-
P2Y11 antagonist NF 340: Assay Workflow
2026-09-12
NF 340 provides a receptor-level way to test how purinergic signaling contributes to QPRT-associated breast cancer invasion, complementing metabolic and downstream pathway inhibitors. This practical guide covers fresh-solution handling, signaling and migration assays, controls, and troubleshooting for reproducible P2Y11 research.
-
PRMT5, Splicing, and Metabolism in Neuroblastoma
2026-09-11
This Cancer Letters study identifies a mechanistic link between PRMT5-dependent splicing, epitranscriptomic regulation, and glutamine metabolism in MYCN-amplified neuroblastoma. Its integrated cell, RNA-sequencing, isotope-tracing, molecular, and mouse-model data suggest that GLS regulation is a downstream component of a broader spliceosomal vulnerability rather than an isolated metabolic defect.
-
APEX2 Control of TERT Expression in Human Stem Cells
2026-09-11
A 2024 preprint identifies APEX2, but not its paralog APEX1, as a determinant of efficient TERT expression and telomerase activity in human embryonic stem cells and melanoma cells. RNA sequencing and chromatin immunoprecipitation connect this effect to APEX2 association with repetitive MIR sequences within the TERT locus, suggesting a DNA-repair-linked layer of transcriptional regulation.
-
SU5416: VEGFR2 Workflows and HIF1 Assays
2026-09-10
SU5416 (Semaxanib) provides a practical way to dissect VEGFR2-dependent endothelial signaling, angiogenesis, and tumor vascularization. Its complementary use in vascular-cell HIF1α studies helps separate receptor-tyrosine-kinase effects from metabolite-driven responses.